Terminalia arjuna (Arjuna) is a well-known medicinal extract whose bark is extensively used in ayurvedic medicine, particularly as cardiac tonic. Arjuna refers to the bark of Terminalia Arjuna; this tree is an evergreen tree that grows in Himalayan forests. Arjuna is a medicinal herb, used in Ayurveda treatment to treat numerous disorders particularly used as a cardiac tonic. Demand for Arjuna bark, both in India and abroad has been growing rapidly for over a decade.
Terminalia arjuna, commonly known as arjuna, belongs to the family of Combretaceae. Its bark decoction is being used in the Indian subcontinent for anginal pain, hypertension, congestive heart failure, and dyslipidemia, based on the observations of ancient physicians for centuries.
Arjuna improves cardiac muscle function and pumping activity of the heart. Its strength of contraction of heart muscle improvement is due to the saponin glycosides. The flavonoids and OPCs provide free radical antioxidant activity and vascular strengthening.
- Arjuna shows improvement in lipid profile; there will be a significant decrease in total cholesterol and LDL cholesterol.
- Arjuna can also normalize high blood pressure.
- COQ10 in Arjuna supports the heart’s energy output, and enhances overall energy levels, stamina, immunity, and boosts antioxidant levels.
- Arjuna herb helps to reduce the effects of stress and nervousness on the heart.
- Arjuna can successfully decrease the persistence of angina attacks. Angina attack is a pain or tightness experiencing in the chest causing due to reduced blood flow to the heart.
- Arjuna shows a significant improvement in patients with congestive heart failure; the patient may find improvement in dyspnea, fatigue, edema and walking tolerance.
- Arjuna can help shed excess body weight.
- Arjuna has compounds that protect against DNA damage from toxins.
Arjuna has shown promise in the following conditions:
- Myocardial Infarction
- Rheumatic Heart Disease
- Ischemic Mitral Regurgitation
- Platelet Aggregation
- Oxidative Stress
- Endothelial Dysfunction
- Thrombotic Condition
Possible Side Effects
Mild side effects like nausea, gastritis, headache, bodyache, constipation, and insomnia have been reported.
Interactions and Precautions
Terminalia Arjuna has been shown to be fine to use with standard heart medications, including digoxin, diuretics, angiotensin-converting-enzyme inhibitors, and vasodilators, without any adverse effects. Always check with your medical professional before taking any new remedy, especially in combination with medications or medical conditions.
Arjuna lessens the ability of the blood to clot, so be cautious if taking blood thinners and always check with your medical professional.
Studies to Dive Into
Tyler VM, Premila MS. Ayurvedic Herbs: A Clinical Guide to the Healing Plants of Traditional Indian Medicine. Available from: http://books.google.co.in/books?id=r7JmIeAw9JAC and printsec=frontcover#v=onepage and q and f=false
Warrier PK, Nambiar VP, Ramankutty C. Indian Medicinal Plants: A Compendium of 500 Species. Available from: http://books.google.co.in/books?id=X2yNfl0PbrgC and q=terminalia+arjuna#v=snippet and q=terminalia%20arjuna and f=false
Chopra RN, Chopra IC, Handa KL, Kapur LD. Chopra RN, Chopra IC, Handa KL, Kapur LD. Chopra’s Indigenous Drugs of India. 1st ed. Calcutta, India: UN Dhur and Sons; 1958. Terminalia arjuna W and A (Combretaceae) pp. 421–4.
Jain S, Yadav PP, Gill V, Vasudeva N, Singla N. Terminalia arjuna a sacred medicinal plant: Phytochemical and pharmacological profile. Phytochem Rev. 2009;8:491–502.
Muthu C, Ayyanar M, Raja N, Ignacimuthu S. Medicinal plants used by traditional healers in Kancheepuram District of Tamil Nadu, India. J Ethnobilol Ethnomed. 2006;2:43. [PMC free article] [PubMed]
Yesodharan K, Sujana KA. Ethnomedicinal knowledge among Malamalasar tribe of Parambikulam Wildlife Sanctuary, Kerala. Indian J Tradit Knowledge. 2007;6:481–5.
Prusti AB, Behera KK. Ethnobotanical exploration of Malkangiri district of Orissa, India. Ethnobot Leafl. 2007;11:122–40.
Prusti AB, Behera KK. Ethno-Medico Botanical Study of Sundargarh district, Orissa, India. Ethnobot Leafl. 2007;11:148–63.
Dwivedi S. Terminalia arjuna Wight and Arn.—A useful drug for cardiovascular disorders. J Ethnopharmacol. 2007;1:114–29. [PubMed]
Arjuna. In hand book on medicinal and aromatic plants. Available from: http://assamagribusiness.nic.in/nedfi/map17.pdf
Dhingra V, Dhingra S, Singla A. Forensic and pharmacognostic studies of the Terminalia Arjuna Bark. Egypt J Forensic Sci. 2013;3:15–9.
Paarakh PM. Terminalia arjuna (Roxb.) Wt. and Arn.: A review. Int J Pharmacol. 2010;6:515–34.
Wang W, Ali Z, Li XC, Shen Y, Khan IA. Triterpenoids from two Terminalia species. Planta Med. 2010;76:1751–4. [PubMed]
Wang W, Ali Z, Li XC, Shen Y, Khan IA. 18,19-secooleanane type triterpene glycosyl esters from the bark of Terminalia arjuna. Planta Med. 2010;76:903–8. [PubMed]
Wang W, Ali Z, Shen Y, Li XC, Khan IA. Ursane triterpenoids from the bark of Terminalia arjuna. Fitoterapia. 2010;81:480–4. [PubMed]
Nema R, Jain P, Khare S, Pradhan A, Gupta A, Singh D. Preliminary phytochemical evaluation and flavanoids quantification of Terminalia arjuna leaves extract. Int J Pharm Phytopharmacol Res. 2012;1:283–6.
Yadava RN, Rathore K. A new cardenolide from the seeds of Terminalia arjuna (W and A) J Asian Nat Prod Res. 2000;2:97–101. [PubMed]
Maulik SK, Talwar KK. Therapeutic potential of Terminalia arjuna in cardiovascular disorders. Am J Cardiovasc Drugs. 2012;12:157–63. [PubMed]
Bhatia J, Bhattacharya SK, Mahajan P, Dwivedi S. Effect of Terminalia arjuna on coronary flow–an experimental study (Abstract) Indian J Pharmacol. 1998;30:118.
Verma P, Muneesh, Rani S, Bhutani G. Experimental Evaluation of Terminalia arjuna (Aqueous Extract) on cardiovascular system in comparison to digoxin. J Dent Med Sci. 2013;7:48–51.
Haq AM, Huque MM, Chaudhury SA, Haque MN. Cardiotonic effects of Terminalia arjuna extracts on guinea pig heart in vitro. Bangladesh J Pharmacol. 2012;7:164–8.
Singh N, Kapur KK, Singh SP, Shankar K, Sinha JN, Kohli RD. Mechanism of cardiovascular action of Terminalia arjuna. Planta Med. 1982;45:102–4. [PubMed]
Takahashi S, Tanaka H, Hano Y, Ito K, Nomura T, Shigenobu K. Hypotensive effect in rats of hydrophilic extract from Terminalia arjuna containing tannin-related compounds. Phytother Res. 1997;11:424–7.
Nammi S, Gudavalli R, Babu BS, Lodagala DS, Boini KM. Possible mechanisms of hypotension produced 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetized dogs. BMC Complement Altern Med. 2003;3:5. [PMC free article] [PubMed]
Oberoi L, Akiyama T, Lee KH, Liu SJ. The aqueous extract, not organic extracts, of Terminalia arjuna bark exerts cardiotonic effect on adult ventricular myocytes. Phytomedicine. 2011;18:259–65. [PubMed]
Gauthaman K, Maulik M, Kumari R, Manchanda SC, Dinda AK, Maulik SK. Effect of chronic treatment with bark of Terminalia arjuna: A study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol. 2001;75:197–201. [PubMed]
Gauthaman K, Mohamed Saleem TS, Ravi V, Patel S, Niranjali S, Devaraj R. Alcoholic extract of terminalia arjuna protects rabbit heart against ischemic-reperfusion injury: Role of antioxidant enzymes and heat shock protein. World Acad Sci Eng Technol. 2008;18:488–98.
Manna P, Sinha M, Sil PC. Phytomedicinal activity of Terminalia arjuna against carbon tetrachloride induced cardiac oxidative stress. Pathophysiology. 2007;14:71–8. [PubMed]
Sinha M, Manna P, Sil PC. Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress. J Med Food. 2008;4:733–40. [PubMed]
Shahriar M, Akhter S, Hossain MI, Haque MA, Bhuiyan MA. Evaluation of in vitro antioxidant activity of bark extracts of Terminalia arjuna. J Med Plants Res. 2012;6:5286–98.
Kokkiripati PK, Kamsala RV, Bashyam L, Manthapuram N, Bitla P, Peddada V, et al. Stem-bark of Terminalia arjuna attenuates human monocytic (THP-1) and aortic endothelial cell activation. J Ethnopharmacol. 2013;146:456–64. [PubMed]
Sumitra M, Manikandan P, Kumar DA, Arutselvan N, Balakrishna K, Manohar BM, et al. Experimental myocardial necrosis in rats: Role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem. 2001;224:135–42. [PubMed]
Reddy TK, Seshadri P, Reddy KK, Jagetia GC, Reddy CD. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage. Phytother Res. 2008;22:1188–94. [PubMed]
Singh G, Singh AT, Abraham A, Bhat B, Mukherjee A, Verma R, et al. Protective effects of Terminaliaarjuna against Doxorubicin-induced cardiotoxicity. J Ethnopharmacol. 2008;117:123–9. [PubMed]
Kumar S, Enjamoori R, Jaiswal A, Ray R, Seth S, Maulik SK. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.) J Pharm Pharmacol. 2009;61:1529–36. [PubMed]
Parveen A, Babbar R, Agarwal S, Kotwani A, Fahim M. Mechanistic clues in the cardioprotective effect of Terminalia arjuna bark extract in isoproterenol-induced chronic heart failure in rats. CardiovascToxicol. 2011;11:48–57. [PubMed]
Mythili P, Parameswari CS, Dayana J. Phytochemical analysis of the bark extract of Terminalia arjuna and its cardioprotective effect. Indian J Innov Dev. 2012;1:40–2.
Tiwari AK, Gode JD, Dubey GP. Effect of Terminalia arjuna on lipid profiles of rabbit fed hypercholesterolemic diet. Int J Crude Drug Res. 1990;28:43–7.
Pathak SR, Upadhya L, Singh RN. Effect of Terminalia arjuna on lipid profile of rabbit fed hypercholesterolemic diet. Int J Crude Drug Res. 1990;28:48–51.
Khanna AK, Chander C, Kapoor NK. Terminalia arjuna: An Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidemic rats. Phytother Res. 1996;10:663–5.
Ram A, Lauria P, Gupta R, Kumar P, Sharma VN. Hypocholesterolaemic effects of Terminaliaarjuna tree bark. J Ethnopharmacol. 1997;55:165–9. [PubMed]
Chander R, Singh K, Khanna AK, Kaul SM, Puri A, Saxena R, et al. Antidyslipidemic and antioxldant activities of different fractions of terminaliaarjuna stem bark. Indian J Clin Biochem. 2004;19:141–8. [PMC free article] [PubMed]
Subramaniam S, Subramaniam R, Rajapandian S, Uthrapathi S, Gnanamanickam VR, Dubey GP. Anti-atherogenic activity of ethanolic fraction of terminaliaarjuna bark on hypercholesterolemic rabbits. Evid Based Complement Alternat Med 2011. 2011 487916. [PMC free article] [PubMed]
Subramaniam S, Ramachandran S, Uthrapathi S, Gnamanickam VR, Dubey GP. Anti-hyperlipidemic and antioxidant potential of different fractions of TerminaliaarjunaRoxb. bark against PX- 407 induced hyperlipidemia. Indian J Exp Biol. 2011;49:282–8. [PubMed]
Sharma S, Sharma D, Agarwal N. Diminishing effect of arjuna tree (Terminalia arjuna) bark on the lipid and oxidative stress status of high fat high cholesterol fed rats and development of certain dietary recipes containing the tree bark for human consumption. Res Pharm. 2012;2:22–30.
Patil RH, Prakash K, Maheshwari VL. Hypolipidemic effect of Terminalia arjuna (L.) in experimentally induced hypercholesteremic rats. Acta Biol Szeged. 2011;55:289–93.
Parmar HS, Panda S, Jatwa R, Kar A. Cardio-protective role of Terminalia arjuna bark extract is possibly mediated through alterations in thyroid hormones. Pharmazie. 2006;61:793–5. [PubMed]
Dwivedi S, Chansouria JP, Somani PN, Udupa KN. Effect of Terminalia arjuna on ischaemic heart disease. Altern Med. 1989;3:115–22.
Jain V, Poonia A, Agarwal RP, Panwar RB, Kochar DK, Mishra SN. Effect of Terminalia arjuna in patients of angina pectoris (A clinical trial) Indian Med Gaz. 1992;36:56–9.
Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminaliaarjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India. 1994;42:287–9. [PubMed]
Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J. 1997;49:507–10. [PubMed]
Kumar PU, Adhikari P, Pereira P, Bhat P. Safety and efficacy of Hartone in stable angina pectoris–an open comparative trial. J Assoc Physicians India. 1999;47:685–9. [PubMed]
Bharani A, Ganguli A, Mathur LK, Jamra Y, Raman PG. Efficacy of Terminaliaarjuna in chronic stable angina: A double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbidemononitrate. Indian Heart J. 2002;54:170–5. [PubMed]
Verma SK, Bordia A. Effect of Terminaliaarjuna bark (arjunchhal) in patients of congestive heart failure and hypertension. J Res Educ Indian Med. 1988;7:31–6.
Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol. 1995;49:191–9. [PubMed]
Ygnanarayan R, Sangle SA, Sirsikar SS, Mitra DK. Regression of cardiac hypertrophy in hypertensive patients—comparison of abana with propanolol. Phytother Res. 1997;11:257–9.
Sandhu JS, Shah B, Shenoy S, Chauhan S, Lavekar GS, Padhi MM. Effects of Withania somnifera (Ashwagandha) and Terminalia arjuna (Arjuna) on physical performance and cardiorespiratory endurance in healthy young adults. Int J Ayurveda Res. 2010;1:144–9. [PMC free article] [PubMed]
Antani JA, Gandhi S, Antani NJ. Terminalia arjuna in congestive heart failure (Abstract) J Assoc Physicians India. 1991;39:801.
Dwivedi S, Aggarwal A, Agarwal MP, Rajpal S. Role of Terminalia arjuna in ischaemic mitral regurgitation. Int J Cardiol. 2005;100:507–8. [PubMed]
Bhawania G, Kumar A, Murthy KS, Kumari N, Swami CG. A retrospective study of effect of Terminalia arjuna and evidence based standard therapy on echocardiographic parameters in patients of dilated cardiomyopathy. J Pharm Res. 2013;6:493–8.
Malik N, Dhawan V, Bahl A, Kaul D. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease. Platelets. 2009;20:183–90. [PubMed]
Pingali U, Fatima N, Nizampatnam M. Evaluation of Terminalia arjuna on cardiovascular parameters and platelet aggregation in patients with Type II diabetes mellitus. Res J Life Sci. 2013;1:7–12.
Tripathi VK, Singh B, Jha RN, Pandey VB, Udupa KN. Studies on Arjuna in coronary heart disease. J Res Ayur Siddha. 2000;21:37–40.
Gupta R, Singhal S, Goyle A, Sharma VN. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: A randomised placebo-controlled trial. J Assoc Physicians India. 2001;49:231–5. [PubMed]
Khalil S. DNB thesis (Medicine) New Delhi, India: National Board of Examination; 2005. Effect of statin versus Terminalia arjuna on acute myocardial infarction.
Kumar G, Srivastava A, Sharma SK, Gupta YK. Safety and efficacy evaluation of Ayurvedic treatment (Arjuna powder and ArogyavardhiniVati) in dyslipidemia patients: A pilot prospective cohort clinical study. Ayu. 2012;33:197–201. [PMC free article] [PubMed]
Dwivedi S, Kumar V. Beta-thalassemia, hyperlipoproteinaemia(a) and metabolic syndrome: Its low cost holistic therapy. J Altern Complement Med. 2007;13:287–9. [PubMed]
Bharani A, Ahirwar LK, Jain N. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian Heart J. 2004;56:123–8. [PubMed]
Shahriar M, Sharmin FA, Islam SMA, Dewan I, Kabir S. Membrane stabilizing and anti-thrombolytic activities of four medicinal Plants of Bangladesh. Experiment. 2012;4:265–70.
Varghese A, Pandita N, Gaud RS. In vitro and in vivo evaluation of CYP1a interaction potential of terminalia arjuna bark. Indian J Pharm Sci. 2014;76:138–47. [PMC free article] [PubMed]